Published: 09 March 2001
Analyst(s): Roddy Martin
Following the Honeywell acquisition of POMS and the subsequent GE acquisition of Honeywell, news about Honeywell-POMS MES developments and new user accounts has been scarce. Although many of the original core Honeywell-POMS team have left, the new Honeywell-POMS team is closer to its goal of regrouping around MES, CMS, and related product extensions, such as eSpec, eKPI, and ePIC. Development activity is progressing with Honeywell-POMS's incorporation into Honeywell's Unified Manufacturing Solutions architecture, efforts to Web-enable information, and integration to major ERP systems, such as J.D. Edwards' World and Oracle's CPG. Honeywell-POMS's vertical focus continues to be Healthcare and CPG. In particular, Biotech has become a growth area as a result of a strong partnership with Cap Gemini Ernst & Young, and several successfully completed large Biotech implementations. Biotech software requirements, such as specification management, inventory control of liquids, and recipe execution, have become a significant focus on development activities.
©2019 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see
Guiding Principles on Independence and Objectivity.